Bolanthus turcicus: a promising antidiabetic with in-vitro antioxidant, enzyme inhibitory and antiadipogenic activities
- PMID: 39729235
- DOI: 10.1007/s10735-024-10283-5
Bolanthus turcicus: a promising antidiabetic with in-vitro antioxidant, enzyme inhibitory and antiadipogenic activities
Abstract
It is crucial to investigate new anti-diabetic agents and therapeutic approaches targeting molecules in potential signaling pathways for the treatment of Type 2 diabetes mellitus (T2DM). The objective of the study was to investigate the total phenolic content, antioxidant capacity, α-glucosidase, and α-amylase inhibitory activities of Bolanthus turcicus (B. turcicus), as well as their cytotoxic, anti-adipogenic, anti-diabetic, apoptotic, and anti-migration potential on adipocytes. B. turcicus samples were extracted with methanol (MeOH), ethyl acetate (EA) and aqueous (Aq) solvents. The MeOH extract had the highest phenolic content (81.14 mg GAE/g), followed by EA (74.93 mg GAE/g) and Aq (51.09 mg GAE/g). All extracts exhibited dose-dependent increases in α-glycosidase and α-amylase inhibitory activity. B. turcicus extracts showed cytotoxic effect on adipocytes with IC50 values of MeOH (141.0 µg/mL) < Aq (155.3 µg/mL) < EA (199.5 µg/mL). Furthermore, B. turcicus extracts reduced lipid droplet formation and adipocyte diameter size. All extracts altered cell morphology to resemble fibroblasts. B. turcicus extracts exhibited anti-migratory effect delaying wound healing for up to 96 h. The B. turcicus extracts showed a pro-apoptotic effects on adipocytes by increasing Caspase-3 enzyme activity and the population of DAPI-positive cell with apoptotic nuclear-morphology. B. turcicus extracts upregulated the expression of the Glut-4 gene at the mRNA, protein and intracellular level in adipocytes. In conclusion, our findings indicate that B. turcicus not only exhibits strong antioxidant properties and enzyme inhibitory activities but also exerts significant anti-adipogenic and pro-apoptotic effects in adipocytes, thereby providing a comprehensive mechanism through which it may contribute to the management of T2DM. These effects highlight the potential of B. turcicus as a therapeutic agent for improving glucose homeostasis and insulin sensitivity.
Keywords: Bolanthus turcicus; Adipocytes; Anti-adipogenic; Anti-diabetic; Cytotoxic; Diabetes mellitus.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Human or animal rights statement: This article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of interest: The authors have no relevant interest to declare. Competing interests: The authors declare no competing interests.
Similar articles
-
Antioxidant, cytotoxic, anti-migratory, and pro-apoptotic effects of Bolanthus turcicus extracts on head and neck cancer cells.Mol Biol Rep. 2024 Oct 30;51(1):1104. doi: 10.1007/s11033-024-09994-5. Mol Biol Rep. 2024. PMID: 39476042
-
Antidiabetic activities of Bolanthus spergulifolius (Caryophyllaceae) extracts on insulin-resistant 3T3-L1 adipocytes.PLoS One. 2021 Jun 16;16(6):e0252707. doi: 10.1371/journal.pone.0252707. eCollection 2021. PLoS One. 2021. PMID: 34133443 Free PMC article.
-
Plant-Based Potential in Diabetes Management: In Vitro Antioxidant, Wound-Healing, and Enzyme Inhibitory Activities of Southern Algarve Species.Molecules. 2025 Jun 1;30(11):2432. doi: 10.3390/molecules30112432. Molecules. 2025. PMID: 40509318 Free PMC article.
-
Antidiabetic Potential of Purple and Red Rice (Oryza sativa L.) Bran Extracts.J Agric Food Chem. 2016 Jul 6;64(26):5345-53. doi: 10.1021/acs.jafc.6b01909. Epub 2016 Jun 22. J Agric Food Chem. 2016. PMID: 27285791
-
Antioxidant, α-Amylase and α-Glucosidase Inhibitory Activities and Potential Constituents of Canarium tramdenum Bark.Molecules. 2019 Feb 9;24(3):605. doi: 10.3390/molecules24030605. Molecules. 2019. PMID: 30744084 Free PMC article.
References
-
- Al-Quran S (2008) Taxonomical and pharmacological survey of therapeutic plants in Jordan. J Nat Prod 1:10–26
-
- Alam F, Islam MA, Khalil MI, Gan SH (2016) Metabolic control of type 2 diabetes by targeting the GLUT4 glucose transporter: intervention approaches. Curr Pharm Design 22(20):3034–3049 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials